Geoffrey Lynn - 17 Dec 2024 Form 3/A - Amendment Insider Report for Barinthus Biotherapeutics plc. (BRNS)

Role
Chief Scientific Officer
Signature
/s/ William Enright, Attorney-in-Fact
Issuer symbol
BRNS
Transactions as of
17 Dec 2024
Transactions value $
$0
Form type
3/A - Amendment
Filing time
31 Dec 2024, 08:39:46
Date Of Original Report
20 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BRNS Ordinary Shares 638K 17 Dec 2024 Direct F1
holding BRNS Ordinary Shares 2.2K 17 Dec 2024 By spouse F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BRNS Share Option (Right to Buy) 17 Dec 2024 Ordinary Shares 175K $11.12 Direct F1, F2
holding BRNS Share Option (Right to Buy) 17 Dec 2024 Ordinary Shares 23.4K $2.40 Direct F1, F3
holding BRNS Share Option (Right to Buy) 17 Dec 2024 Ordinary Shares 24.2K $3.70 Direct F1, F4
holding BRNS Share Option (Right to Buy) 17 Dec 2024 Ordinary Shares 200K $0.98 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vested on January 3, 2023.
F3 The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vested on January 3, 2024.
F4 The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 2, 2025.
F5 The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on December 1, 2025.

Remarks:

This amendment to the Form 3 originally filed on December 20, 2024 is being filed solely to correct the number of Ordinary Shares beneficially owned by the Reporting Person's spouse.